ARO-AAT

United States

adminOctober 9, 2020
9

Takeda and Arrowhead Collaborate to Co-Develop and Co-Commercialize ARO-AAT for Alpha-1 Antitrypsin-Associated Liver Disease

Japan & United States: − Potential first-in-class therapy designed to treat the underlying cause of liver disease associated…
Read More »